Does CERTOLIZUMAB PEGOL Cause Nasopharyngitis? 5,295 Reports in FDA Database

Q: Does CERTOLIZUMAB PEGOL cause Nasopharyngitis?

5,295 reports of Nasopharyngitis have been filed with the FDA for CERTOLIZUMAB PEGOL, representing 5.3% of all CERTOLIZUMAB PEGOL adverse event reports.

Q: How dangerous is Nasopharyngitis from CERTOLIZUMAB PEGOL?

Of 5,295 reports, 1,293 (24.4%) resulted in death and 1,921 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5,295 reports of Nasopharyngitis have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 5.3% of all adverse event reports for CERTOLIZUMAB PEGOL.

5,295

Reports of Nasopharyngitis with CERTOLIZUMAB PEGOL

5.3%

of all CERTOLIZUMAB PEGOL reports

1,293

Deaths

1,921

Hospitalizations

How Dangerous Is Nasopharyngitis From CERTOLIZUMAB PEGOL?

Of the 5,295 reports, 1,293 (24.4%) resulted in death, 1,921 (36.3%) required hospitalization, and 1,423 (26.9%) were considered life-threatening.

Is Nasopharyngitis Listed in the Official Label?

Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for CERTOLIZUMAB PEGOL.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663)